Cite
Soares Romeiro LA, da Costa Nunes JL, de Oliveira Miranda C, et al. Novel Sustainable-by-Design HDAC Inhibitors for the Treatment of Alzheimer's Disease. ACS Med Chem Lett. 2019;10(4):671-676doi: 10.1021/acsmedchemlett.9b00071.
Soares Romeiro, L. A., da Costa Nunes, J. L., de Oliveira Miranda, C., Simões Heyn Roth Cardoso, G., de Oliveira, A. S., Gandini, A., Kobrlova, T., Soukup, O., Rossi, M., Senger, J., Jung, M., Gervasoni, S., Vistoli, G., Petralla, S., Massenzio, F., Monti, B., & Bolognesi, M. L. (2019). Novel Sustainable-by-Design HDAC Inhibitors for the Treatment of Alzheimer's Disease. ACS medicinal chemistry letters, 10(4), 671-676. https://doi.org/10.1021/acsmedchemlett.9b00071
Soares Romeiro, Luiz Antonio, et al. "Novel Sustainable-by-Design HDAC Inhibitors for the Treatment of Alzheimer's Disease." ACS medicinal chemistry letters vol. 10,4 (2019): 671-676. doi: https://doi.org/10.1021/acsmedchemlett.9b00071
Soares Romeiro LA, da Costa Nunes JL, de Oliveira Miranda C, Simões Heyn Roth Cardoso G, de Oliveira AS, Gandini A, Kobrlova T, Soukup O, Rossi M, Senger J, Jung M, Gervasoni S, Vistoli G, Petralla S, Massenzio F, Monti B, Bolognesi ML. Novel Sustainable-by-Design HDAC Inhibitors for the Treatment of Alzheimer's Disease. ACS Med Chem Lett. 2019 Mar 29;10(4):671-676. doi: 10.1021/acsmedchemlett.9b00071. eCollection 2019 Apr 11. PMID: 30996816; PMCID: PMC6466821.
Copy
Download .nbib